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IB-IVUS derived tissue components (calcification, dense fibrosis, fibrosis, lipid pool) and
fibrous cap thickness were investigated.
Results: The percent changes in fibrous cap thickness correlated negatively and
significantly with the percent changes in external elastic membrane cross sectional area
(r-0.5, P0.0001). The %changes in fibrous cap thickness correlated negatively and
significantly with %changes in lipid pool area (r-0.61, P0.0001). The %changes in
fibrous cap thickness correlated positively with calcification, dense fibrosis or fibrosis, as
well (r0.44, P0.0001, r0.60, P0.0001, and r0.54, P0.0001, respectively).
Conclusions: Arterial remodeling with changes in lipid pool component is related to
changes in fibrous cap thickness. Positive arterial remodeling with lipid accumulation may
represent an unstable or vulnerable process of the coronary arterial plaque.
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The Evolution of Thin-Capped Fibroatheroma in Left Main Coronary Artery
As Assessed by Serial Virtual Histology Intravascular Ultrasound Analysis
Sang-Wook Kim1, Sung Yun Lee2, Gary Mintz3, Young Joon Hong4,
Wang-Soo Lee1, JeeEun Kwon1, Kwang Jae Lee1, CheeJeong Kim5, TaeHo Kim5,
Neil Weissman6
1Chung-Ang University Hospital, Seoul, Korea, Republic of, 2Inje University Ilsan
Paik Hospital, Goyang-si, Korea, Republic of, 3CRF, washington, United States,
4Heart Research Center, Chonnam National University Hospital, Gwangju, Korea,
Republic of, 5Chung-Ang University Healthcare System, Seoul, Korea, Republic of,
6MedStar Washington Hosp Center, Washington, USA
Background: Statin theraphy have been shown the regression of coronary artery plaque.
However a few data was reported about the change of left main coronary artery.
Methods: We used Virtual Histology Intravascular Ultrasound (VH-IVUS) to assess
mild to moderate left main coronary artery (LMCA) disease in 500 consecutive pts and
identified 50 pts with who had serial VH-IVUS examinations at baseline and at follow-up
at 12 months. VH-TCFA (thin-capped fibroatheroma) was defined as necrotic core (NC)
10% of plaque area with a plaque burden of 40% and NC in contact with the lumen
for 3 image slices. Positive remodeling was a remodeling index (lesion/reference EEM
[external elastic membrane] area) 1.05.
Results: Pt age was 5713 yrs and 20% were diabetics. The incidence of LM-TCFA was
11.2% (56/500). following 16 pts with VH-TCFA at baseline and serial VH-IVUS, distal
reference lumen area was 14.64.2 mm2. LMCA length was 6.44.0mm, and the rate of
positive remodeling was 14% (8/56). 74% of VH-TCFA were located in mid-body of the
LMCA and the rest at the distal bifurcation. After 12 months of statin therapy, minimal
lumen area (12.83.8 to 12.44.5 mm2, p0.6) and maximum %NC (28.013.2 to
27.212.1, p0.8) were similar; and only 37.5% (6/16) of VH-TCFA had healed to a
non-VH-TCFA phenotype and 3 new VH-TCFA appeared (Table) even though low
density lipoprotein (LDL) level was decreased in 87.5 % (14/16) pts with 12/16 having an
LDL 100mg/dL.
Conclusions: Healing of VH-TCFA in the LMCA is not high during “routine” statin
therapy. This suggests the need for more strict control of risk factors in these pts.
Follow-up
Baseline
PIT
(n14)
ThCFA
(n5)
TCFA
(n13)
Fibrotic
(n12)
Fibrocalcific
(n6)
PIT (n14) 14
ThCFA (n1) 1
TCFA (n16) 1 10 3 2
Fibrotic (n15) 3 3 9
Fibrocalcific (n4) 4
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elevation acute myocardial infarction: TAMI-R study
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Background: Thin capped fibroatheroma(TCFA) is a principal pathophysiologic mech-
anism to occur acute coronary syndrome. However, the characteristics of each TCFA have
not been evaluated.
Methods: We used virtual histology-intravascular ultrasound (VH-IVUS) to assess
culprit lesions in 196 consecutive pts with ST elevation acute myocardial infarction
(STEMI) and compared culprit lesions in the RCA (59 pts) with culprit lesions in the left
coronary artery (LCA, 137 pts). VH-thin-capped fibroatheromas (VH-TCFAs) were
defined as necrotic core (NC) 10% of plaque area, plaque burden 40%, and NC in
contact with the lumen for 3 image slices.
Results: Plaque ruptures were seen in 85/196 of which 52 were located in the proximal
30mm of a coronary artery. Lesion length was similar; vessel size, plaque burden,
minimal lumen area, and average %NC were larger; and VH-TCFA phenotype was more
common (60% vs 31%, p0.001) in RCA vs LCA-STEMI (Table). Importantly, culprit
lesion plaque ruptures were more common in RCA (45.5%) vs LAD-STEMI (30.1%,
p0.034) as was the frequency of VH-TCFA phenotype in the setting of culprit plaque
ruptures (72% in RCA vs 29% in LAD-STEMI, p0.005).
Conclusions: Plaque ruptures are not always detected by IVUS in culprit lesions of pts
presenting with STEMI, and VH-TCFA phenotype is not always seen in these culprit
lesions whether or not plaque rupture is detected. Rather, plaque rupture and VH-TCFA
phenotype in culprit lesions of STEMI pts appear to depend on location (RCA vs LCA)
and vessel size.
RCA LCA p-value
Lesion length (mm) 20.60	/7.81 23.39	/10.29 0.200
Distal reference lumen
area (mm2)
9.06	/4.05 6.84	/3.32 0.002
Minimal lumen area
(mm2)
4.52	/2.58 3.49	/1.85 0.007
Vessel area (mm2)
(ruptured site)
21.00	/6.00 16.83	/5.09 0.004
Lumen area (mm2)
(ruptured site)
7.59	/2.81 6.05	/2.33 0.020
Plaque area (mm2)
(ruptured site)
11.31	/3.92 8.30	/3.41 0.027
Ruptured cavity (mm2) 1.18	/1.05 0.83	/0.69 0.145
Remodeling index (@
ruptured site)
1.04	/0.19 1.13	/0.29 0.193
average fibrotic plaque (%) 59.96	/10.32 58.09	/13.43 0.425
average fibrofatty plaque
(%)
10.08	/5.34 9.60	/5.57 0.606
average necrotic core (%) 20.52	/8.42 17.38	/7.73 0.020
average dense calcium (%) 8.66	/6.06 10.51	/7.01 0.118
VH-IVUS phenotype 0.02
Pathologic intimal
thickening
2 8
Thick cap fibrotheroma 0 1
VH-TCFA 22 21
Fibrotic 2 13
Fibrocalcific
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High Level of Copeptin in ST elevation Acute Myocardial Infarction patients
is associated with In-Hospital Mortality and Plaque Rupture; TAMI-COP
study
Sang-Wook Kim1, Gary Mintz2, Wang Soo Lee1, EunYoung Kim1, Jun Hwan Jo1,
KwangJe Lee1, CheeJeong Kim1, TaeHo Kim1, Neil Weissman3
1Chung-Ang University Hospital, Seoul, Korea, Republic of, 2CRF, washington,
United States, 3MedStar Washington Hosp Center, Washington, USA
Background: Copeptin has been known to predict heart failure and cardiovascular death
in patients with acute coronary syndrome.
Methods: We collected coronary arterial blood samples from the infarct artery during
primary percutaneous coronary intervention (PCI) in 80 STEMI pts and 28 controls. We
assessed commonly used cardiac biomarkers (CK, CK-MB, troponin-I, CRP) and
additionally measured recently introduced biomarkers (Copeptin [C-terminal Provaso-
pressin] and N-terminal pro-B-type natriuretic peptide [NT-proBNP]).
Results: Pt age was 5812 yrs and 93% were males. Intravascular ultrasound (IVUS) of
the culprit lesion in 80 pts showed ruptured plaques in 36 pts. STEMI pts had a higher
Copeptin level (265.89183.10 pmol/L) vs193.6760.17 pmol/L in normal controls,
p0.005. Especially, Copeptin levels were higher in ruptured plaque compared to
non-ruptured plaques: 318.83209.34 pmol/L vs 221.99151.49 pmol/L, p0.034.
While troponin I, CK-MB, and CRP were not correlated with Copeptin, NT-proBNP was
correlated with copeptin (r0.579, p0.0003). In hospital death occurred in 7 pts with a
high Copeptin level (figure); all were due to cardiogenic shock after primary PCI.
Conclusions: Copeptin levels are associated with plaque rupture in STEMI pts and
predict mortality after primary PCI.
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Two year Clinical Impact of Postprocedural Incomplete Stent Apposition and
Late Acquired Incomplete Stent Apposition After Deployment of Zotarolimus
Eluting Stent or Everolimus Eluting Stent
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Jei-Keon Chae1, Jae-Ki Ko1
1Chonbuk National University Hospital, Jeonju, Korea, Republic of, 2Presbyterian
medical center, Jeonju, Korea, Republic of, 3WonKwang University Hospital,
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Background: We already reported the preliminary data for the one year clinical impact
of post-procedural incomplete stent apposition (PISA) and late incomplete stent apposi-
tion (LISA) in the newer generation of drug eluting stent. The aim of this study was to
investigate the clinical impact of LISA and PISA during 24-month clinical follow up.
Methods: We prospectively enrolled 178 patients who underwent percutaneous coronary
intervention (PCI) in de novo coronary lesions; stable angina (n41), unstable angina
(n91), and non-ST segment elevation myocardial infarction (n46) (63.79.4 years,
125 male, 187 lesions). The group was randomly assigned (proportion of 1:2) to
everolimus eluting stent (group I, n65, Xience V, Abbott Vascular, Illinois) or
zotarolimmus eluting stent (group II, n122, Endeavor Resolute, Medtronic, MN).
Post-PCI and follow up intravascular ultrasound (IVUS, mean 10.22.9 months) were
performed in all patients. We analyzed 24-month major adverse cardiac events including
death, myocardial infarction (MI) and target lesion failure (TLR).
Results: The Post-PCI external elastic membrane (EEM) volume vs follow up EEM
volume (group I: 368.0169.6 mm3 vs 373.6167.2 mm3, pNS, group II:
431.0167.5 vs 440.1172.0 mm3, pNS), and post-PCI lumen volume vs follow up
lumen volume (group I: 203.086.8 vs 201.786.0 mm3, pNS, group II: 239.292.7
vs 239.592.5 mm3, pNS) by IVUS were not different. There were three LISAs [1.6%,
group I (n1) vs group II (n2)] and sixty four PISAs [34.2%, group I (n24 vs group
II (n40)] that were resolved [12.5%, group I (n2) vs group II (n6)]. Post-PCI and
follow up volume of PISA was not significantly different in both group I (6.44.3 vs
6.33.9 mm3, pNS) and group II (6.45.3 vs 6.24.3 mm3, pNS). Both PISA and
LISA were not related with cardiac death or MI during 24-month clinical follow up.
However, there were four TLRs in PISA subgroup [6.3%, group I (n0) vs group II
(n4)].
Conclusions: The incidence of LISA was low in both groups. Both PISA and LISA were
not related with cardiac death or MI during 24-month clinical follow up. Future long-term
follow up study to clarify the clinical course of LISA and PISA would be needed to
confirm our results.
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Background: Rotational atherectomy (ROTA) is a safe and effective treatment of severe
calcified coronary lesions. It works by differential ablation of the inelastic components of
the atherosclerotic plaque, in particular the calcified areas. However this has never been
characterized in vivo. New tissue characterization techniques coupled with intracoronary
ultrasound (IVUS), like iMap®(BSC, Mn), make this possible.
Methods: We present a prospective study conducted in pts submitted to ROTA under
IVUS guidance using a 40 MHz probe with tissue characterization. Plaque morphology
and composition was assessed pre and post ROTA. All pts had severely calcified coronary
artery disease and an indication for rotablation. After collection, data was sent to an
independent reviewer who was not present during the procedure. Plaque composition was
quantified with QIVUS (Medis) according to percentage fibrotic, lipid, necrotic, calcified
and unknown components.
Results: 20 lesions with an exact landmark matching between basal and post ROTA were
analyzed, after an increment in burr of 0.25-0.50 mm. Luminal area increased on average
0.99  0.82 mm2 due to removal of an average 24.5  12.0% of plaque area. Plaque
composition analysis showed that most of the removed plaque was fibrotic tissue (56%),
followed by calcified (19%) and/or necrotic (18%). Lipid component had little change.
Conclusions: For the first time it was possible to demonstrate in vivo the mechanism of
plaque removal by rotablation. This data confirms the ability of ROTA to remove inelastic
plaque, not only calcified but also fibrotic tissue, which was predominant.
TCT-280
Acute and Long-term Prognostic Impact of Attenuated Plaque in Patients
with Acute Coronary Syndrome
Hiroyuki Okura1, Nobuya Matsushita2, Toru Kataoka2, Teruyoshi Kume1,
Kiyoshi Yoshida1
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Background: Several studies have reported that culprit lesion attenuated plaque assessed
by intravascular ultrasound (IVUS) is related to slow/no-reflow after percutaneous
coronary intervention (PCI). Long-term prognostic impact of the culprit lesion attenuated
plaque is unknown.The aim of this study was to investigate acute and long-term clinical
impact of the attenuated plaque in patients with acute coronary syndrome (ACS).
Methods: A total of 110 ACS patients who underwent successful PCI under IVUS
guidance were enrolled and studied. Acute and long-term clinical outcomes were
compared between patients with attenuated plaque (n73) and those without attenuated
plaque (non-attenuated plaque: n37). Long-term cardiac event was defined as a
composite of death and ACS.
Results: Baseline characteristics in 2 groups were similar. Attenuated plaque was
associated with higher TIMI frame count immediate after the first balloon inflation. After
thrombectomy and intracoronary drug administration, final TIMI frame count became
similar between attenuated and non-attenuated plaque. Although attenuated plaque was
associated with higher incidence of fatal arrhythmia during hospitalization, in hospital
mortality did not differ between the 2 groups. During follow-up (median 6.2 years),
cardiac event-free survival was similar between the 2 groups (Figure).
Conclusions: Despite the initial unfavorable effect on coronary reflow, presence of
attenuated plaque did not affect acute as well as long-term clinical outcome in patients
with ACS, possibly as a result of adjunctive pharmacological or aspiration therapies.
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